VOR Earnings — Vor Biopharma Inc. Common Stock Post-ER Performance | BigEarnings
VOR — Vor Biopharma Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$14.97
Market Cap$811.2M
P/E—
52W Range$3.63 – $65.80
Next Earnings2026-08-11
About Vor Biopharma Inc. Common Stock
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
